Figure 1.
Frequency of molecular and therapeutic subgroups based on the ELN 2022 classification modified from Rausch et al,2who reported frequencies of ELN 2022 subgroups from an intensively treated AML cohort (n = 1118) with a median age of 58 years (range, 18-86 years).2 mut, mutated; wt, wild type.